A23V 2250/1612
Manganese
A23V2250/1612 (Manganese) appears on 4 US grants and 6 published applications in this corpus.
Search patents in A23V- Granted patents
- 4
- Published applications
- 6
- Assignees
- 5
- Inventors
- 18
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 3 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Nutritional compositions and infant formula for promoting de novo myealination21 Jul 2026US 12,685,331 B2Societe des Produits Nestle S. A.
- Enzyme-rich malt extract (ERME) formulations11 Jun 2024US 12,005,098 B2Pepsis Limited
- Nutritional formulations and kits for bariatric individuals4 Jan 2022US 11,213,059 B2Mantra Pharma
- Nutritional formulations using human milk oligosaccharides for modulating inflammation21 Apr 2020US 10,624,916 B2Abbott Laboratories
- Nutritional formulations using human milk oligosaccharides for modulating inflammation23 Jul 2020US 2020/0230162 A1Abbott Laboratories
- Enzyme-rich malt extract (erme) formulations10 Oct 2019US 2019/0307859 A1Pepsis Limited
- Compositions and methods for avoiding, reducing, and reversing undesirable visual and olfactory effects in food products4 Jul 2019US 2019/0200656 A1Chew LLC
- Nutritional formulations and kits for bariatric individuals27 Jun 2019US 2019/0191754 A1Mantra Pharma
- Nutritional formulations using human milk oligosaccharides for modulating inflammation8 Sep 2016US 2016/0256479 A1Abbott Laboratories
Most cited
By later US patents